IQV vs SILO · P/E 23, rev $16.31B vs rev $18.0K
IQVIA Holdings Inc (IQV) versus Silo Pharma Inc (SILO) — a side-by-side from cached financials, not a winner call.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Silo Pharma Inc (SILO) is a biotechnology company listed on US.
Latest reported IQV revenue for 2025-12-31 was $16.31B. Net income was $1.36B. Revenue was up 5.9% from 2024-12-31 to 2025-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Latest reported SILO revenue for 2026-06-30 was $18.0K. Net income was -$2.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SILO currently screens at market cap $4.4M.
IQV currently screens at market cap $30.62B and trailing P/E 22.8. SILO currently screens at market cap $4.4M.
Not investment advice. Open the IQV and SILO stock pages for the full models.
Not investment advice.